reslizumab   Click here for help

GtoPdb Ligand ID: 8091

Synonyms: CDP-835 | CDP835 | Cinqaero® | Cinqair® | JES1-39D10 | SCH55700
Approved drug Immunopharmacology Ligand
reslizumab is an approved drug (EMA & FDA (2016))
Compound class: Antibody
Comment: Reslizumab is a monoclonal antibody with antiinflammatory action. It is designed to treat eosinophil-driven inflammatory conditions of the airways, skin and gastrointestinal tract [1,4].
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: reslizumab

Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
IL-5 Primary target of this compound Hs Antibody Binding 8.1 pKd - 1
⤷ pKd 8.1 (Kd 8.9x10-9 M) [1]